VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,961,342 | -9.9% | 184,368 | +0.8% | 0.32% | -3.3% |
| Q2 2023 | $5,509,347 | +6.1% | 182,974 | +14.0% | 0.33% | -2.9% |
| Q1 2023 | $5,191,786 | +657.2% | 160,488 | +570.8% | 0.34% | +568.6% |
| Q4 2022 | $685,690 | +28.6% | 23,925 | +8.3% | 0.05% | -1.9% |
| Q3 2022 | $533,000 | -13.6% | 22,084 | -2.1% | 0.05% | -10.3% |
| Q2 2022 | $617,000 | -31.9% | 22,551 | -4.5% | 0.06% | -18.3% |
| Q1 2022 | $906,000 | +54.9% | 23,625 | +29.3% | 0.07% | +57.8% |
| Q4 2021 | $585,000 | +57.7% | 18,275 | +67.4% | 0.04% | +73.1% |
| Q2 2021 | $371,000 | +10.4% | 10,916 | +5.5% | 0.03% | 0.0% |
| Q1 2021 | $336,000 | -19.6% | 10,344 | -10.9% | 0.03% | -23.5% |
| Q4 2020 | $418,000 | +7.2% | 11,609 | +16.7% | 0.03% | +13.3% |
| Q3 2020 | $390,000 | +1.3% | 9,950 | -5.4% | 0.03% | 0.0% |
| Q2 2020 | $385,000 | +56.5% | 10,519 | -2.5% | 0.03% | 0.0% |
| Q1 2020 | $246,000 | -18.0% | 10,784 | +4.9% | 0.03% | +150.0% |
| Q4 2019 | $300,000 | +18.6% | 10,276 | +8.4% | 0.01% | -53.8% |
| Q3 2019 | $253,000 | -34.6% | 9,476 | -42.5% | 0.03% | -56.7% |
| Q2 2017 | $387,000 | -7.2% | 16,479 | -7.4% | 0.06% | +42.9% |
| Q1 2017 | $417,000 | – | 17,804 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |